Skip to main content
. 2022 Apr 6;5:326. doi: 10.1038/s42003-022-03251-w

Fig. 4. GSTM2 regulated lipid droplet accumulation via ASK1-p38/JNK signalling.

Fig. 4

a, b Phosphorylation of ASK1 was up-regulated by GSTM2 KD and down-regulated by GSTM2 OE. c, d p-p38 and p-JNK levels were up-regulated by GSTM2 knockdown (KD) and down-regulated by GSTM2 OE. e GSTM2 OE down-regulated ASK1-p38/JNK signalling in the presence of palmitic acid treatment. f GSTM2 interacted with ASK1 by co-IP detection. g GSTM2 C-terminal, not N-terminal, down-regulated ASK1 activity. h SREBF1 and PLIN2 expression level was up-regulated by GSTM2 KD. i SREBF1 and PLIN2 expression level was down-regulated by GSTM2 OE. j More LDs were observed in cells with SREBF1 or PLIN2 overexpression. k Statistical analysis of number of LDs in cells with SREBF1 or PLIN2 overexpression. l Expression levels of SREBF1 and PLIN2 were down-regulated by GS-4997 treatment (ASK1 activity inhibitor). m Statistical analysis of number of LDs in shGSTM2 cells and shGSTM2 cells treated with GS-4997. n WB detection of SREBF1 and PLIN2 in shGSTM2 cells treated with PA. o WB detection of SREBF1 and PLIN2 in shGSTM2 cells treated with GS-4997. Bar, 10 μm.